PROTECTIVE EFFECT OF LIPOSOMAL-AMPHOTERICIN-B AGAINST C-ALBICANS INFECTION IN MICE

[1] INFLUENCE OF EXTRACELLULAR K+ OR MG-2+ ON THE STAGES OF THE ANTIFUNGAL EFFECTS OF AMPHOTERICIN-B AND FILIPIN [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (04) : 593 - 597

[2] FUNGAL-INFECTIONS IN PATIENTS WITH ACUTE-LEUKEMIA [J]. AMERICAN JOURNAL OF MEDICINE, 1982, 73 (04) : 543 - 548

[3] GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.1093/biomet/52.1-2.203

[4] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481

[5] KASI LP, 1984, INT J NUCL MED BIOL, V1, P35

[6] LIPOSOMAL AMPHOTERICIN-B FOR THE TREATMENT OF SYSTEMIC FUNGAL-INFECTIONS IN PATIENTS WITH CANCER - A PRELIMINARY-STUDY [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (04) : 704 - 710

[7] TREATMENT AND PROPHYLAXIS OF DISSEMINATED INFECTION DUE TO CANDIDA-ALBICANS IN MICE WITH LIPOSOME-ENCAPSULATED AMPHOTERICIN-B [J]. JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (05) : 939 - 945

[8] PROPHYLAXIS OF CANDIDA-ALBICANS INFECTION IN NEUTROPENIC MICE WITH LIPOSOME-ENCAPSULATED AMPHOTERICIN-B [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) : 366 - 367

[9] EFFECTS OF STEROLS ON THE THERAPEUTIC EFFICACY OF LIPOSOMAL AMPHOTERICIN-B IN MURINE CANDIDIASIS [J]. CANCER DRUG DELIVERY, 1983, 1 (01): : 37 - 42

[10] ALTERED TISSUE DISTRIBUTION OF AMPHOTERICIN-B BY LIPOSOMAL ENCAPSULATION - COMPARISON OF NORMAL MICE TO MICE INFECTED WITH CANDIDA-ALBICANS [J]. CANCER DRUG DELIVERY, 1984, 1 (03): : 199 - 205

[1] INFLUENCE OF EXTRACELLULAR K+ OR MG-2+ ON THE STAGES OF THE ANTIFUNGAL EFFECTS OF AMPHOTERICIN-B AND FILIPIN [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (04) : 593 - 597

[2] FUNGAL-INFECTIONS IN PATIENTS WITH ACUTE-LEUKEMIA [J]. AMERICAN JOURNAL OF MEDICINE, 1982, 73 (04) : 543 - 548

[3] GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.1093/biomet/52.1-2.203

[4] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481

[5] KASI LP, 1984, INT J NUCL MED BIOL, V1, P35

[6] LIPOSOMAL AMPHOTERICIN-B FOR THE TREATMENT OF SYSTEMIC FUNGAL-INFECTIONS IN PATIENTS WITH CANCER - A PRELIMINARY-STUDY [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (04) : 704 - 710

[7] TREATMENT AND PROPHYLAXIS OF DISSEMINATED INFECTION DUE TO CANDIDA-ALBICANS IN MICE WITH LIPOSOME-ENCAPSULATED AMPHOTERICIN-B [J]. JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (05) : 939 - 945

[8] PROPHYLAXIS OF CANDIDA-ALBICANS INFECTION IN NEUTROPENIC MICE WITH LIPOSOME-ENCAPSULATED AMPHOTERICIN-B [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) : 366 - 367

[9] EFFECTS OF STEROLS ON THE THERAPEUTIC EFFICACY OF LIPOSOMAL AMPHOTERICIN-B IN MURINE CANDIDIASIS [J]. CANCER DRUG DELIVERY, 1983, 1 (01): : 37 - 42

[10] ALTERED TISSUE DISTRIBUTION OF AMPHOTERICIN-B BY LIPOSOMAL ENCAPSULATION - COMPARISON OF NORMAL MICE TO MICE INFECTED WITH CANDIDA-ALBICANS [J]. CANCER DRUG DELIVERY, 1984, 1 (03): : 199 - 205